Expert Insights: From animal to iPSC-derived models, a new era in preclinical ...
Research highlights: Targeted Protein Degradation in Tauopathies
Case Study: Development of a human iPSC-derived ALS model
-1.png)
The status of drug discovery and development for Parkinson's disease
Uncovering ALS pathology and potential drug targets with in vitro iPSC models
The status of drug discovery and development for Alzheimer's disease
Research highlights: Target identification to modulate neuroinflammation in ...
Case Study: Modeling Friedreich’s ataxia using patient-derived iPSCs
Adoption of complex disease modeling brings new optimism and hope to drug discovery
Whitepaper: Advancing drug discovery for neurodegenerative diseases
Webinar: Alternative preclinical models to revolutionize cardiac and CNS drug ...
Webinar: Unlocking the secrets of muscular disease using iPSC models
Webinar: Human iPSC added value to the drug discovery pipeline
Webinar: iPSCs in gene therapy: Potent Solutions
Science, Innovation and Hope: How to advance drug discovery for neurodegenerative ...
Webinar: iPSC-based 3D microtissues and their applications in drug discovery
Webinar: The potential of iPSC-derived endothelial cells for efficacy and safety ...
Webinar: Developing novel human iPSC models for atrial fibrillation
Webinar: Assessment of drug-induced structural toxicity in human iPSC-derived ...
Webinar Series: Modeling Neurodegenerative Diseases
FDA Modernization Act 2.0: FDA no longer requires all drugs to be tested on animals ...
Press release: Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses ...
Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO
Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer
Press release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC ...
Press release: Cell & gene therapy accelerator to de-risk early stage research
Optimization of the Ncyte Astrocyte Kit
Press release: improving the early detection, prevention and treatment of lung ...
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of ...
iCone Consortium hits milestone in large-scale production of iPSC-derived cortical ...
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
